Literature DB >> 20150892

Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival.

Matthias Drosten1, Alma Dhawahir, Eleanor Y M Sum, Jelena Urosevic, Carmen G Lechuga, Luis M Esteban, Esther Castellano, Carmen Guerra, Eugenio Santos, Mariano Barbacid.   

Abstract

We have used mouse embryonic fibroblasts (MEFs) devoid of Ras proteins to illustrate that they are essential for proliferation and migration, but not for survival, at least in these cells. These properties are unique to the Ras subfamily of proteins because ectopic expression of other Ras-like small GTPases, even when constitutively active, could not compensate for the absence of Ras proteins. Only constitutive activation of components of the Raf/Mek/Erk pathway was sufficient to sustain normal proliferation and migration of MEFs devoid of Ras proteins. Activation of the phosphatidylinositol 3-kinase (PI3K)/PTEN/Akt and Ral guanine exchange factor (RalGEF)/Ral pathways, either alone or in combination, failed to induce proliferation or migration of Rasless cells, although they cooperated with Raf/Mek/Erk signalling to reproduce the full response mediated by Ras signalling. In contrast to current hypotheses, Ras signalling did not induce proliferation by inducing expression of D-type Cyclins. Rasless MEFs had normal levels of Cyclin D1/Cdk4 and Cyclin E/Cdk2. However, these complexes were inactive. Inactivation of the pocket proteins or knock down of pRb relieved MEFs from their dependence on Ras signalling to proliferate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20150892      PMCID: PMC2845279          DOI: 10.1038/emboj.2010.7

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  60 in total

Review 1.  RAS oncogenes: the first 30 years.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

Review 2.  Compartmentalized signalling: Ras proteins and signalling nanoclusters.

Authors:  Jasminka Omerovic; Ian A Prior
Journal:  FEBS J       Date:  2009-02-23       Impact factor: 5.542

Review 3.  Many faces of Ras activation.

Authors:  László Buday; Julian Downward
Journal:  Biochim Biophys Acta       Date:  2008-05-21

4.  Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors.

Authors:  R Sotillo; P Dubus; J Martín; E de la Cueva; S Ortega; M Malumbres; M Barbacid
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

5.  Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene.

Authors:  M Mikula; M Schreiber; Z Husak; L Kucerova; J Rüth; R Wieser; K Zatloukal; H Beug; E F Wagner; M Baccarini
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

Review 6.  Role of Rho-family proteins in cell adhesion and cancer.

Authors:  Angeliki Malliri; John G Collard
Journal:  Curr Opin Cell Biol       Date:  2003-10       Impact factor: 8.382

7.  Mek2 is dispensable for mouse growth and development.

Authors:  Louis-François Bélanger; Sophie Roy; Michel Tremblay; Barbara Brott; Ann-Muriel Steff; Walid Mourad; Patrice Hugo; Raymond Erikson; Jean Charron
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

8.  Role of ERas in promoting tumour-like properties in mouse embryonic stem cells.

Authors:  Kazutoshi Takahashi; Kaoru Mitsui; Shinya Yamanaka
Journal:  Nature       Date:  2003-05-29       Impact factor: 49.962

9.  Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context.

Authors:  Carmen Guerra; Nieves Mijimolle; Alma Dhawahir; Pierre Dubus; Marta Barradas; Manuel Serrano; Victoria Campuzano; Mariano Barbacid
Journal:  Cancer Cell       Date:  2003-08       Impact factor: 31.743

10.  Analysis of R-Ras signalling pathways.

Authors:  A J Self; E Caron; H F Paterson; A Hall
Journal:  J Cell Sci       Date:  2001-04       Impact factor: 5.285

View more
  124 in total

1.  Constitutive K-RasG12D activation of ERK2 specifically regulates 3D invasion of human pancreatic cancer cells via MMP-1.

Authors:  Gregory P Botta; Mauricio J Reginato; Maximilian Reichert; Anil K Rustgi; Peter I Lelkes
Journal:  Mol Cancer Res       Date:  2011-12-08       Impact factor: 5.852

2.  RalA and RalB proteins are ubiquitinated GTPases, and ubiquitinated RalA increases lipid raft exposure at the plasma membrane.

Authors:  Vincent Neyraud; Vasily N Aushev; Anastassia Hatzoglou; Brigitte Meunier; Ilaria Cascone; Jacques Camonis
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

Review 3.  RAS-targeted therapies: is the undruggable drugged?

Authors:  Amanda R Moore; Scott C Rosenberg; Frank McCormick; Shiva Malek
Journal:  Nat Rev Drug Discov       Date:  2020-06-11       Impact factor: 84.694

Review 4.  KRAS as a Therapeutic Target.

Authors:  Frank McCormick
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

5.  Design of Small Molecules That Compete with Nucleotide Binding to an Engineered Oncogenic KRAS Allele.

Authors:  Yan Zhang; Marie-Hélène Larraufie; Leila Musavi; Hemanth Akkiraju; Lewis M Brown; Brent R Stockwell
Journal:  Biochemistry       Date:  2018-02-06       Impact factor: 3.162

6.  Genetic evidence that β-arrestins are dispensable for the initiation of β2-adrenergic receptor signaling to ERK.

Authors:  Morgan O'Hayre; Kelsie Eichel; Silvia Avino; Xuefeng Zhao; Dana J Steffen; Xiaodong Feng; Kouki Kawakami; Junken Aoki; Karen Messer; Roger Sunahara; Asuka Inoue; Mark von Zastrow; J Silvio Gutkind
Journal:  Sci Signal       Date:  2017-06-20       Impact factor: 8.192

7.  A KRAS GTPase K104Q Mutant Retains Downstream Signaling by Offsetting Defects in Regulation.

Authors:  Guowei Yin; Samantha Kistler; Samuel D George; Nora Kuhlmann; Leslie Garvey; Minh Huynh; Rachel K Bagni; Michael Lammers; Channing J Der; Sharon L Campbell
Journal:  J Biol Chem       Date:  2017-01-30       Impact factor: 5.157

8.  Depletion of K-Ras promotes proteasome degradation of survivin.

Authors:  Awet Tecleab; Saïd M Sebti
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

9.  Functional redundancy of Sos1 and Sos2 for lymphopoiesis and organismal homeostasis and survival.

Authors:  Fernando C Baltanás; Martín Pérez-Andrés; Alicia Ginel-Picardo; David Diaz; David Jimeno; Pilar Liceras-Boillos; Robert L Kortum; Lawrence E Samelson; Alberto Orfao; Eugenio Santos
Journal:  Mol Cell Biol       Date:  2013-09-16       Impact factor: 4.272

10.  MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival.

Authors:  Chih-Shia Lee; Liam C Lee; Tina L Yuan; Sirisha Chakka; Christof Fellmann; Scott W Lowe; Natasha J Caplen; Frank McCormick; Ji Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.